| 前收市價 | 2,661.00 |
| 開市 | 0.00 |
| 買盤 | 2,661.01 x 無 |
| 賣出價 | 0.00 x 無 |
| 今日波幅 | 2,661.00 - 2,661.00 |
| 52 週波幅 | 1,356.97 - 2,708.33 |
| 成交量 | |
| 平均成交量 | 2,095 |
| 市值 | 無 |
| Beta 值 (5 年，每月) | 0.15 |
| 市盈率 (最近 12 個月) | 42.86 |
| 每股盈利 (最近 12 個月) | 62.09 |
| 業績公佈日 | 2024年8月07日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 無 |
Investor's Business DailyBiden Just Knocked Eli Lilly Stock Off Its Pedestal — Is It A Buy Or A Sell?
Is Eli Lilly stock a buy or a sell after Joe Biden called out Lilly and Novo Nordisk for high drug prices? Is LLY stock a buy or a sell?
Yahoo FinanceFighting words: Lilly and Novo swat back at the Biden/Sanders call for lower GLP-1 prices
President Joe Biden and Sen. Bernie Sanders have called on Danish drugmaker Novo Nordisk to reduce its pricing for GLP-1s. It and Eli Lilly respond.
Motley FoolSurprise! Novo Nordisk's Wegovy Just Achieved Another Milestone. Here's What You Need to Know.
Wegovy was just approved in China.
